Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8563)
All Articles published online
|
Publishing Process of This Article
|
Apr 28, 2020 (publication date) through Jan 29, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Novillo A, Gaibar M, Romero-Lorca A, Gilsanz MF, Beltrán L, Galán M, Antón B, Malón D, Moreno A, Fernández-Santander A. Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports. World J Gastroenterol 2020; 26(16): 1979-1986 [PMID: 32390708 DOI: 10.3748/wjg.v26.i16.1979] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Novillo A, Gaibar M, Romero-Lorca A, Gilsanz MF, Beltrán L, Galán M, Antón B, Malón D, Moreno A, Fernández-Santander A. Efficacy of bevacizumab-containing chemotherapy in metastatic colorectal cancer and CXCL5 expression: Six case reports. World J Gastroenterol 2020; 26(16): 1979-1986 [PMID: 32390708 DOI: 10.3748/wjg.v26.i16.1979] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i16/1979.htm |
| Number | Citing Articles |
| 1 |
Benny Mosoane, Georgios Lolas, Zodwa Dlamini. Colorectal Cancer Treatment Resistance. 2025; : 25 doi: 10.1016/B978-0-443-33475-7.00014-7
|
| 2 |
Kim Da Hye, Oleksandr V. Petrenko, Hana T. Desta. Association of FGF2, CD39, ANGPT1, and MMP9 Genetic Variants with Clinical Outcomes in Metastatic Colorectal Cancer Patients Treated with Bevacizumab and Chemotherapy. Bulletin of Pioneering Researches of Medical and Clinical Science 2025; 5(2): 140 doi: 10.51847/8If8C706AZ
|
| 3 |
Mauri Dobbs Spendlove, Trenton M. Gibson, Shaney McCain, Benjamin C. Stone, Tristan Gill, Brett E. Pickett. Pathway2Targets: an open-source pathway-based approach to repurpose therapeutic drugs and prioritize human targets. PeerJ 2023; 11: e16088 doi: 10.7717/peerj.16088
|
| 4 |
Ahmed M. Kabel, Ahmed M. Ashour, Dina A. Ali, Hany H. Arab. The immunomodulatory effects of topiramate on azoxymethane-induced colon carcinogenesis in rats: The role of the inflammatory cascade, vascular endothelial growth factor, AKT/mTOR/MAP kinase signaling and the apoptotic markers. International Immunopharmacology 2021; 98: 107830 doi: 10.1016/j.intimp.2021.107830
|
| 5 |
Dong-Sheng Sun, Cang-Hai Guan, Wei-Na Wang, Zeng-Tao Hu, Yu-Qiao Zhao, Xing-Ming Jiang. LncRNA NORAD promotes proliferation, migration and angiogenesis of hepatocellular carcinoma cells through targeting miR-211-5p/FOXD1/VEGF-A axis. Microvascular Research 2021; 134: 104120 doi: 10.1016/j.mvr.2020.104120
|
| 6 |
María Gaibar, Miguel Galán, Alicia Romero-Lorca, Beatriz Antón, Diego Malón, Amalia Moreno, Ana Fernández-Santander, Apolonia Novillo. Genetic Variants of ANGPT1, CD39, FGF2 and MMP9 Linked to Clinical Outcome of Bevacizumab Plus Chemotherapy for Metastatic Colorectal Cancer. International Journal of Molecular Sciences 2021; 22(3): 1381 doi: 10.3390/ijms22031381
|
| 7 |
Monika Zajkowska, Maciej Dulewicz, Agnieszka Kulczyńska-Przybik, Kamil Safiejko, Marcin Juchimiuk, Marzena Konopko, Leszek Kozłowski, Barbara Mroczko. CXCL5 and CXCL14, but not CXCL16 as potential biomarkers of colorectal cancer. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-45093-4
|
| 8 |
Lara J. Bou Malhab, Maha M. Saber-Ayad, Ranyah Al-Hakm, Vidhya A. Nair, Panagiotis Paliogiannis, Gianfranco Pintus, Wael M. Abdel-Rahman. Chronic Inflammation and Cancer: The Role of Endothelial Dysfunction and Vascular Inflammation. Current Pharmaceutical Design 2021; 27(18): 2156 doi: 10.2174/1381612827666210303143442
|
| 9 |
Amina T. Mneimneh, Nadine Darwiche, Mohammed M. Mehanna. Investigating the therapeutic promise of drug-repurposed-loaded nanocarriers: A pioneering strategy in advancing colorectal cancer treatment. International Journal of Pharmaceutics 2024; 664: 124473 doi: 10.1016/j.ijpharm.2024.124473
|
| 10 |
|
| 11 |
Mehtap Cevik, Esat Namal, Nur Dinc-Sener, Ulkuhan Iner-Koksal, Cavlan Ciftci, Belgin Susleyici. Investigation of Vascular Endothelial Growth Factor Polymorphisms on Risk, Metastasis, Laterality, and Prognosis of Colorectal Cancer in Turkish Subjects. Genetic Testing and Molecular Biomarkers 2022; 26(5): 298 doi: 10.1089/gtmb.2021.0213
|